| Not Yet Recruiting | Navigation Intervention for Adolescent and Young Adult Cancer Survivors NCT07406087 | Kaiser Permanente | N/A |
| Recruiting | Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy NCT06828185 | Loma Linda University | N/A |
| Not Yet Recruiting | Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) NCT07407582 | University of Arizona | Phase 1 / Phase 2 |
| Recruiting | Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer NCT07498959 | Sahlgrenska University Hospital | N/A |
| Not Yet Recruiting | Virtual Testis Cancer Lay Support and Survivorship Aim 2 NCT06702592 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496 | University of Arizona | Phase 1 / Phase 2 |
| Recruiting | A Study of GV20-0251 in Advanced or Refractory Solid Tumors NCT07106827 | West China Hospital | Phase 1 |
| Recruiting | A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced G NCT06866964 | Wake Forest University Health Sciences | Phase 2 |
| Active Not Recruiting | Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Ca NCT07228637 | Indiana University | N/A |
| Recruiting | A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Li NCT06932458 | Western University, Canada | Phase 2 |
| Recruiting | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Can NCT06371768 | Duke University | N/A |
| Recruiting | Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer NCT06954233 | Jagiellonian University | — |
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329 | Brian Henick, MD | Phase 1 |
| Withdrawn | A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors NCT06681870 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Recruiting | Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of R NCT06684327 | Fudan University | Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses. NCT06620016 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph NCT06593665 | Indiana University | Phase 3 |
| Recruiting | Digital Peer Navigation for Adolescents and Young Adults With Cancer NCT06193369 | University Health Network, Toronto | N/A |
| Recruiting | A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors NCT06515613 | Context Therapeutics Inc. | Phase 1 |
| Not Yet Recruiting | Unveiling Patient Experiences in Testicular Cancer Clinical Trials NCT05928377 | Power Life Sciences Inc. | — |
| Unknown | Role of Elastography in Diagnosis of Testicular Tumors NCT06231329 | Ali Mohamed Alaa El-din | — |
| Not Yet Recruiting | WEST-KOaST Study: WES Analysis of Testicular Cancer Patientsand Their First-degree Family Members NCT06142500 | IRCCS San Raffaele | N/A |
| Recruiting | A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors NCT05836688 | University of California, Irvine | N/A |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest NCT05899361 | Dana-Farber Cancer Institute | N/A |
| Active Not Recruiting | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer NCT05946993 | University College Cork | N/A |
| Terminated | Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers a NCT05819827 | Mayo Clinic | — |
| Completed | Testicular Self-Examination Awareness in Young Men NCT06318182 | Hitit University | N/A |
| Recruiting | Follow-up After Surgery for Testicular Cancer NCT05670938 | Erasmus Medical Center | — |
| Terminated | Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors NCT05611307 | Indiana University | — |
| Recruiting | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively NCT05840575 | Rigshospitalet, Denmark | — |
| Recruiting | Early Ageing During Therapy in AYA Cancer Patients NCT05062707 | University Medical Center Groningen | — |
| Recruiting | Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral NCT06806917 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe NCT04935255 | Radboud University Medical Center | — |
| Completed | The Impact of the COVID-19 Pandemic on Testicular Cancer NCT05083143 | Ankara Training and Research Hospital | — |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Recruiting | Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants NCT05097820 | University Hospital, Ghent | — |
| Active Not Recruiting | Endocrine Disrupting Chemical Exposure and Testicular Cancer NCT04848545 | Rigshospitalet, Denmark | — |
| Completed | Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemot NCT04180033 | The Netherlands Cancer Institute | N/A |
| Completed | The Effect of the Brochure on Testicular Self-Exam NCT05073198 | Selcuk University | N/A |
| Active Not Recruiting | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma NCT03937843 | Swiss Cancer Institute | Phase 2 |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Recruiting | Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study NCT04113122 | University Medical Center Groningen | N/A |
| Completed | Short-term Testosterone Replacement in Testicular Cancer Survivors NCT03339635 | University Medical Center Groningen | Phase 2 |
| Completed | Role of Axumin PET Scan in Germ Cell Tumor NCT03426865 | University of Texas Southwestern Medical Center | — |
| Recruiting | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774 | Massive Bio, Inc. | — |
| Active Not Recruiting | WATChmAN Virtual Testicular Cancer Clinic NCT03360994 | University Health Network, Toronto | N/A |
| Unknown | Development of Diagnostics and Treatment of Urological Cancers NCT02994758 | Helsinki University Central Hospital | N/A |
| Completed | Intermediate and Long Term Vascular Effects of Cisplatin in Patients With Testicular Cancer NCT03557164 | NHS Greater Glasgow and Clyde | — |
| Completed | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers NCT02643303 | Ludwig Institute for Cancer Research | Phase 1 / Phase 2 |
| Completed | Study of Testosterone vs Placebo in Testicular Cancer Survivors NCT02991209 | Mikkel Bandak | Phase 2 / Phase 3 |
| Completed | Clinical Characterisation of the Vascular Effects of Cis-platinum Based Chemotherapy in Patients With Testicul NCT03557177 | NHS Greater Glasgow and Clyde | — |
| Completed | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer NCT02860819 | National Cancer Institute, Slovakia | Phase 2 |
| Completed | Early Life Exposures in Agriculture NCT02743481 | National Cancer Institute (NCI) | — |
| Terminated | Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors NCT02689219 | Nabil Adra | Phase 2 |
| Completed | Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Pa NCT02602041 | University Medical Center Groningen | — |
| Completed | Vascular Fingerprint Validation Study NCT02573584 | University Medical Center Groningen | — |
| Active Not Recruiting | Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study) NCT02572934 | University Medical Center Groningen | — |
| Terminated | Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer NCT02478502 | University Hospital, Akershus | Phase 2 |
| Completed | Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumo NCT02429466 | Nasser Hanna | Phase 1 |
| Active Not Recruiting | TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects NCT02276430 | University Medical Center Groningen | — |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Completed | Physical Activity and Testicular Cancer NCT01749774 | Oslo University Hospital | N/A |
| Completed | REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg NCT02092740 | University of Magdeburg | — |
| Active Not Recruiting | Shared Care Follow-up After Chemotherapy for Testicular Cancer NCT01783145 | University Medical Center Groningen | — |
| Completed | Taste, Smell and Chemotherapy (TASTY) NCT01641172 | University Medical Center Groningen | Phase 4 |
| Completed | Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging NCT01482741 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies NCT01242072 | Alaunos Therapeutics | Phase 1 |
| Completed | Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer NCT01242631 | Hannover Medical School | Phase 2 |
| Recruiting | Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients NCT06389409 | IRCCS San Raffaele | — |
| Completed | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors NCT00936936 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | B-Receptor Signaling in Cardiomyopathy NCT01135849 | Daniel Bernstein | — |
| Unknown | Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy NCT00772694 | Fondation Wygrajmy Zdrowie | Phase 2 |
| Completed | Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients NCT00705094 | AHS Cancer Control Alberta | — |
| Terminated | Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer NCT00531687 | Rigshospitalet, Denmark | Phase 2 |
| Completed | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced C NCT00423254 | Mannkind Corporation | Phase 1 |
| Active Not Recruiting | Low-Dose CT - Stage I Testicular Cancer NCT03142802 | University Health Network, Toronto | N/A |
| Completed | Relationship of Ochratoxin A to Upper Urologic Cancers NCT00216801 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Terminated | Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk NCT00820287 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma NCT00183820 | University of Southern California | Phase 2 |
| Completed | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases NCT00587964 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Genetics of Familial Testicular Cancer NCT00342537 | National Cancer Institute (NCI) | — |
| Completed | Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metas NCT01684098 | Endocyte | Phase 2 |
| Completed | Cause of Familial Testicular Cancer NCT00034424 | National Cancer Institute (NCI) | — |
| Completed | A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen NCT00341588 | National Cancer Institute (NCI) | — |